Health CanadaGeneral Alert
AVASTIN (bevacizumab) – Reports of Cases of Severe Eye Inflammation Leading to B...
Published: December 7, 2011Recall ID: 24449Category: generalCountry: Canada
Product Description & Identification
AVASTIN (bevacizumab) – Reports of Cases of Severe Eye Inflammation Leading to Blindness Following Use in the Eye – For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24449 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/avastin-bevacizumab-reports-cases-severe-eye-inflammation-leading-blindness-following |
| Title | AVASTIN (bevacizumab) – Reports of Cases of Severe Eye Inflammation Leading to Blindness Following Use in the Eye – For the Public |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2011-12-07 |
| Organization | Marketed health products |